Stocks
RLMD
Venrock Adviser, LLC

Venrock Adviser, LLC

CIK

1615982

City

NEW YORK

State / Country

NY

Stock

RLMD — Relmada Therapeutics, Inc.

Top Portfolio Positions

33 positions · $2,679,121,844 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio
APGE	Apogee Therapeutics, Inc. Healthcare	8,493,321	$714,882,828	26.68%
ERAS	Erasca, Inc. Healthcare	16,382,812	$265,073,898	9.89%
ORKA	Oruka Therapeutics, Inc. Healthcare	4,148,428	$203,480,393	7.60%
SYRE	Spyre Therapeutics, Inc. Healthcare	3,685,448	$185,893,997	6.94%
KALV	KalVista Pharmaceuticals, Inc. Healthcare	6,474,485	$130,331,383	4.86%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	1,180,000	$99,025,600	3.70%
DMRA	Damora Therapeutics, Inc. Healthcare	3,603,595	$93,333,110	3.48%
OCUL	Ocular Therapeutix, Inc Healthcare	10,346,926	$87,638,463	3.27%
COGT	Cogent Biosciences, Inc. Healthcare	2,000,000	$76,980,000	2.87%
VRDN	Viridian Therapeutics, Inc.\DE Healthcare	3,882,709	$75,945,788	2.83%

Portfolio Trend

25 quarters · across all stocks

Holdings in RLMD

Compact Export CSV

Shares Held

Position Value (USD)

12 of 12 shown

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$33,709,924	4,843,380	+219.1%	Shares	Sole	2026-05-15
2022-09-30	$56,198,433	1,518,056	-33.1%	Shares	Sole	2023-05-15
2022-06-30	$43,108,667	2,270,072	0.0%	Shares	Sole	2023-05-15
2022-03-31	$61,269,243	2,270,072	0.0%	Shares	Sole	2022-05-16
2021-12-31	$51,144,722	2,270,072	+63.6%	Shares	Sole	2022-02-14
2021-09-30	$36,372,141	1,387,720	0.0%	Shares	Sole	2021-11-15
2021-06-30	$44,420,917	1,387,720	+62.6%	Shares	Sole	2021-08-13
2021-03-31	$30,041,383	853,206	+27.6%	Shares	Sole	2021-05-14
2020-12-31	$21,436,870	668,440	0.0%	Shares	Sole	2021-02-12
2020-09-30	$25,146,712	668,440	0.0%	Shares	Sole	2020-11-16
2020-06-30	$29,912,690	668,440	-20.7%	Shares	Sole	2020-08-14
2020-03-31	$28,748,385	842,814	—	Shares	Sole	2020-05-15
No quarters match your search.